2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics 2008 Barcelona - European Society of Human Genetics
Molecular and biochemical basis of disease P06.177 sequence analysis of circadian clock modulators miR-132 and miR-219 and their targets RFX4 and PHLPP in mood Disorder Patients E. Saus 1 , V. Soria 2 , F. Vivarelli 1 , J. M. Crespo 2,3 , J. M. Menchón 2,3 , M. Urretavizcaya 2,3 , X. Estivill 1,4 , M. Gratacòs 1 ; 1 CIBERESP (CIBER en Epidemiología y Salud Pública), Genes and Disease Program and CeGen Barcelona Genotyping Node, Center for Genomic Regulation, Barcelona, Catalonia, Spain, 2 Mood Disorders Clinical and Research Unit, CIBER-SAM, Psychiatry Department, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Catalonia, Spain, 3 Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona, Catalonia, Spain, 4 Experimental and Health Sciences Department, Pompeu Fabra University, Barcelona, Catalonia, Spain. It has been widely supported that circadian rhythms are involved in the pathophysiology of mood disorders (MD). Two brain-specific miRNAs (microRNAs) have been recently reported as modulators of endogenous circadian clock located in the suprachiasmatic nucleus in mice . The authors have functionally characterized miR-132 and miR-219 within the context of circadian clock and gave experimental evidences of genes Rfx4 and Phlpp as respective targets. We first explored the conservation between species for both miRNAs and once the existence of hsa-miR-132 and hsa-miR-219 was corroborated in humans, we used different prediction programs to check the experimentally supported target sites RFX4 and PHLPP in humans. Specifically, mi- Randa predicted hsa-miR-132 to target RFX4 and TargetScan predicted PHLPP as a target site for hsa-miR-219, consistent with previous work in mice . Once both miRNAs with their respective target sites were confirmed in humans, we questioned whether these two miRNAs and their target genes RFX4 and PHLPP are altered in mood disorder patients . Thus, we re-sequenced both miRNAs and their respective target sites at RFX4 and PHLPP genes in a sample consisting of 365 unrelated patients (218 Unipolar Major Depressive Disorder and 147 Bipolar Disorder) diagnosed according to DSM-IV criteria . All patients completed the Spanish versions of the Seasonal Pattern Assessment Questionnaire and the Horne-Östberg Morningness-Eveningness Questionnaire. This is the first time that the circadian clock regulation by miRNAs is explored in mood disorder, representing a first step to elucidate the underlying mechanism of these proteins and the role of these miRNAs in mood disorders . P06.178 Allelic frequencies and heterozygosities of microsatellite markers covering the whole genome in the Korean J. Lee, M. Park, K. Kim, H. Lee, K. Kim, J. Jung, B. Oh, H. Kim; Center for Genome Science, National Institute of Health, Seoul, Republic of Korea. Microsatellite markers are an essential tool for genetic linkage analysis because of their high polymorphism content . Four hundred commercially available markers covering the entire genome were genotyped from 578 sib individuals from 249 Korean families . Allelic frequencies and heterozygosities were determined for each marker loci and compared between Korean, Taiwanese, Japanese and Caucasian populations . In the three Asian populations, 10-13% of the markers had less than 0 .6 heterozygosity, whereas in the Caucasian population, only 0 .5% of the markers had less than 0 .6 heterozygosity . Mean identical by descent (IBD) values were calculated for 578 sib individuals .Analysis of IBD values greater than 0 .5 suggested that markers with low heterozygosity can also provide positive linkages, at least for the IBD sharing method of model-free linkage analysis . The data presented in this study will be a useful reference for genome-wide screens of Koreans and comparative studies with other ethnic populations . P06.179 Association study of migraine and 19 candidate genes involved in serotoninergic neurotransmission in a spanish population R. Corominas 1 , M. J. Sobrido 2,3 , E. Cuenca-León 1 , P. Blanco 4,3 , B. Narberhaus 5 , M. Del Toro 1 , R. Leira 6 , J. López 6 , M. Ribasés 1 , A. Macaya 1 , B. Cormand 7,3 ; 1 Hospital Universitari Vall d’Hebron, Barcelona, Spain, 2 Fundación Pública Galera de Medicina Xenómica, Santiago de Compostela, Spain, 3 CIBER Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain, 4 Grupo de Medicina Xenómica, Universidad de Santiago de Compostela, Santiago de Compostela, Spain, 5Hospital General de Manresa, Manresa, Spain, 6Servicio de Neurología, Hospital Clínco de Santiago, Santiago de Compostela, Spain, 7Departament de Genètica, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain. Migraine is a common neurological disorder with a complex inheritance pattern . Although the pathophysiology of the disease is not well understood, several studies suggest that serotonin-related genes may participate in its pathogenesis . The involvement of some of these genes has been studied in different migraine populations with conflicting results thus far . In the present study we aimed to evaluate the possible role of 19 genes involved in serotoninergic neurotransmission in the susceptibility to migraine in a Spanish population using a case-control approach based on SNPs . A total sample of 528 unrelated patients were recruited and diagnosed following the IInd International Criteria of Headache Disorders from the IHS (308 patients had migraine without aura and 220 had migraine with aura) and compared to 528 sex-matched controls in which migraine was ruled out . All individuals were Spanish of Caucasoid origin from Catalonia and Galicia . SNP selection was based on genetic coverage parameters and genotyping was performed using SNPlex technology . Chi-square tests were used for the comparison of allele and genotype frequencies between the patient and control groups for each single SNP . Preliminary data of nominal associations suggest a contribution of HTR1E, HTR2B, HTR3B, MAOA and DDC in the genetic predisposition to migraine . P06.180 Genetic diagnosis of Ataxia telangectasia and role of mitochondria on it M. Houshmand; NIGEB, Tehran, Islamic Republic of Iran. Ataxia telangiectasia (AT) is an autosomal recessive disorder in 1/40,000 to 1/100,000 in reported populations . There is a 25% possibility for having an affected child when parents are carrier for the ATM gene mutation . There is no cure available for this disease and prenatal testing is strongly recommended for prevention of this disease . Although the preferred method is the direct mutation analysis of the ATM gene, the large size of the ATM gene with 63 exons and the large number of possible mutations in patients considerably limit efficiency of mutation analysis as a diagnostic choice. In this study, four molecular markers: D11S2179, D11S1787, D11S535, D11S1343 are genotyped in 19 unrelated families from different regions of Iran . All carriers and affected patients were diagnosed accurately . This method is effectively useful in prenatal diagnosis of AT . We also investigated mt-DNA deletions and haplogroups in AT patients . In this study, 24 Iranian patients suffering from AT and 100 normal controls were examined . mt-DNA was extracted from whole blood and examined by 6 primers for existence of mitochondrial deletions . We also amplified and sequenced the mtDNA HVS-I by standard sequencing techniques . mtDNA deletions were observed in 54 .1% (13/24) of patients (8 .9 kb deletion in all samples, 5 .0 kb in one and 7 .5 kb in two patients), representing mtDNA damage which may be due to oxidative stress in mitochondria . Our results showed that there is no association between mtDNA haplogroups and AT . This data may indicate involvement of mitochondrial damage in the pathogenesis of AT . P06.181 Role of mitochondria in Friedreich Ataxia M. Houshmand; NiGEB, Tehran, Islamic Republic of Iran. Friedreich’s Ataxia (FA) is the commonest genetic cause of ataxia and is associated with the expansion of a GAA repeat in intron 1 of the frataxin gene . Mitochondrial DNA (mtDNA) could be considered a candidate modifier factor for FA disease, since mitochondrial oxidative stress is thought to be involved in the pathogenesis of this disease . The expansion (GAA) repeat in the first intron causes decreased frataxin expression by interfering with transcription .: Activity of mitochondrial respiratory chain complex I (measured as NADH ferricyanide reductase) and intracellular ATP measurement was performed on lymphocyte of FA patients (n =12) and control subjects (n =25) . Common deletion were identified and confirmed by southern blotting in FA patients. Homozygous GAA expansion was found in 21 (84%) of all cases . In four cases (16%), no expansion was observed, ruling out the diagnosis
Molecular and biochemical basis of disease of Friedreich’s ataxia . In cases with GAA expansions, ataxia, scoliosis and pes cavus, cardiac abnormalities and some neurological findings occurred more frequently than in our patients without GAA expansion . mtDNA deletions were present in 76% of our patients representing mtDNA damage, which may be due to iron accumulation in mitochondria. Our findings showed that complex I activities and intracellular ATP were significantly reduced (P=0.001) in patients compared with control . 8 .6 kb deletion in mtDNA was detected in all of patients by multiplex PCR but Southern blot analysis confirmed the presence of deletion in 9 of 12 patients . P06.182 the developmental changes in mitochondrial DNA content per cell in human liver and muscle tissue during gestation M. Pejznochova, M. Magner, M. Tesarova, H. Hansikova, J. Zeman; Faculty of Medicine, Prague, Czech Republic. The process of oxidative phosphorylation system (OXPHOS) maturation is still not fully understood during the development of the fetus . Since all mammalian cells except erythrocytes depend on mitochondrial ATP production, knowledge of the OXPHOS maturation is an essential query. Our previous study demonstrated significant changes of mitochondrial DNA (mtDNA) content in cord blood leukocytes during the gestation . To futher understand the role of mtDNA content in human prenatal development, we analyzed mtDNA amount in human fetal liver and muscle tissue during the gestation . DNA was isolated from 26 liver and 26 muscle tissue samples obtained at autopsy from miscarriages between 13 th and 28 th week of gestation . The mtDNA amount was analyzed by the real-time PCR method using SybrGreen I (Chromo4, Bio-Rad) . The significant positive correlations were found between the gestational age and the relative mtDNA amount in fetal liver tissue (r = 0,56; p < 0,01) and mtDNA amount in fetal muscle tissue (r = 0,61; p < 0,01), respectively . In both fetal liver and muscle tissue, mtDNA content per cell was increasing with onward fetal development . These results are in accordance with the few of studies but there was never analysed as numerous set of tissue samples as in our study . Presently we analyze a relation among changes of the mtDNA content during prenatal development and the transcription activation of some mtDNA maintenance factors (NRF1, TFAM) in the same set of tissue samples . This work was supported by grant GAUK 25755707, IGA MZ-NR 9410,GACR 305 08 H037 . P06.183 Duplication analysis of the DmD gene by mLPA technique J. Juan, M. Rodríguez, L. González-Quereda, L. Sedano, E. del Río, E. Tizzano, M. Baiget, P. Gallano; Hospital Sant Pau, Barcelona, Spain. Duchenne and Becker muscular dystrophies (DMD/BMD) are the most common form of dystrophinopathies, with a reported incidence of 1:3500 and 1:18000 birth males, repectively . About 65% of DMD/BMD cases are attributable to large deletions of the DMD gene, whereas the remaining cases are caused by duplications or point mutations of the gene . The exact frequency of these two last types of mutations is not known . The detection of duplications in Duchenne (DMD)/ Becker muscular dystrophy (BMD) has long been overlooked . Recent techniques such as multiplex ligation-dependent probe amplification (MLPA) have simplified the detection of duplications. We report here 20 duplications recently detected in BMD/DMD unrelated patients using MLPA technique . Although the reading frame rule could be applied in most patients, it was not applied in 2 DMD patients . Special care was taken with one patient presenting non contiguous rearrangements: c.[2623_2950dup; 11047_11055del], a duplication of exons 21 and 22, and a deletion of exon 79 . The majority of the duplications clustered towards 5’ end of the gene . The availability of new quantitative methods including MLPA has aroused interest in duplication detection analysis in DMD gene . The MLPA technique enables us to test all the 79 exons, allowing the detection of a significant number of new duplications. We report the duplications in patients in whom a previous molecular screening did not show any deletion . P06.184 A novel mLPA technique for copy number analysis on small amounts of DNA K. M. Sorensen 1 , P. S. Andersen 1 , L. A. Larsen 2 , M. Schwartz 3 , J. Schouten 4 , A. Nygren 4 ; 1 Statens Serum Institut, Kbh. S, Denmark, 2 Wilhelm Johannsen Centre of Functional Genome Research, Kbh. N, Denmark, 3 Department of Clinical Genetics, Rigshospitalet, Kbh. N, Denmark, 4 MRC Holland, Amsterdam, The Netherlands. Background: The MLPA technique was introduced in 2002 as a new sensitive technique for relative quantification of up to 40 different nucleic acid sequences in a single, extremely easy to perform, reaction . Today the technique is routinely used for copy number analysis in various syndromes and diseases . Aim: The aim is to exploit the potential of MLPA in areas where DNA material is limited . The DNA concentration required in standard MLPA analysis is not attainable from dried blood spot samples (DBS) often used in neonatal screening programs . By redesigning the MLPA probes we attempt to perform MLPA analysis on small amounts of DNA . Patients and methods: 7 patients with Congenital Adrenal Hyperplasia (CAH) were used in this study . DNA was extracted from both whole blood and DBS, and subjected to MLPA analysis using SALSA P050B probemix (normal and modified probes). Results were analysed using GeneMarker (Softgenetics) and Excel spreadsheet analysis . Results: We found a 99 .6% concordance of the results obtained with DNA extracted from whole blood compared with DNA from dried blood spot samples . Conclusion: We demonstrate that MLPA reactions with modified probes are functional and reliable at very low DNA concentrations . This broadens the diagnostic perspectives of biobanks consisting of DBS allowing for CNV analysis in general and particularly testing for CAH . This study is supported by the SAFE Network of Excellence P06.185 is sNPs in MSX gene playing a role in the development of cleft palate (CP) or cleft lip/palate (CLP)? B. Lace 1 , I. Vasiljeva 2 , I. Dundure 1 , B. Barkane 3 , I. Akota 3 , A. Krumina 1 ; 1 Dept. of Med.Biology and Genetics, Riga, Latvia, 2 Biomedical study and research centre, Riga, Latvia, 3 RSU, Institute of Stomatology, Riga, Latvia. MSX1 gene role in the development of cleft palate and cleft lip/palate and oligodontia has been confirmed in several studies. MSX1 (member of muscle segment homeobox gene family) gene expression is related to transcription repression during embriogenesis and craniofacial development . It was confirmed, that mutations in MSX1 gene approximately in 2% can cause nonsyndromic CL/CLP . Results were replicated in studies involving different populations . Objective of our study was to evaluate role of mutations and also SNPs in MSX1 gene in Latvian nonsyndromic CP and CLP patients . Materials and methods . DNA from 101 persons with CP or CLP was extracted from venous blood (CP- 21, CL/CLP-80) . Promoter region, exons, introns boundaries and 3` UTR region were sequenced . Results . One mutation 457G>C in exon 2 and 16 SNPs in MSX1 gene was identified. Thirteen of them were described earlier and were commonly met in Caucasian populations, three of them were not observed in previous studies . Interestingly two SNPs, who were localized in intron 1 451+(41-51)del and 3`UTR 3969 A>G showed higher frequencies in nonsyndromic CLP patients (0 .41;0 .38 respectively) than in CP patients (0 .17;0 .14) . Conclusions . Considerable difference observed between SNPs in patients with CP and CLP, who had localised in the non-coding regions, raise suggestions about their possible role in the development of nonsyndromic CLP . P06.186 Association of c677t and A1298c polymorphisms in the methylenetetrahydrofolate reductase (mtHFR) gene with cervical dysplasia in Yucatan, mexico L. J. Gonzalez-Herrera1 , P. Rodriguez-Morales1 , V. Fernández-Gonzalez1 , I. Rosado-Lopez2 , T. Canto de Cetina1 ; 1 2 Universidad Autonoma de Yucatan, Merida, Mexico, Clinica de displasias del Hospital O´Horán, Merida,Yucatan, Mexico. The influence of MTHFR activity on DNA methylation, synthesis and repair, presents MTHFR as a candidate cancer-predisposing gene . 0
- Page 281 and 282: Molecular and biochemical basis of
- Page 283 and 284: Molecular and biochemical basis of
- Page 285 and 286: Molecular and biochemical basis of
- Page 287 and 288: Molecular and biochemical basis of
- Page 289 and 290: Molecular and biochemical basis of
- Page 291 and 292: Genetic analysis, linkage, and asso
- Page 293 and 294: Molecular and biochemical basis of
- Page 295 and 296: Molecular and biochemical basis of
- Page 297 and 298: Molecular and biochemical basis of
- Page 299 and 300: Molecular and biochemical basis of
- Page 301 and 302: Molecular and biochemical basis of
- Page 303 and 304: Molecular and biochemical basis of
- Page 305 and 306: Molecular and biochemical basis of
- Page 307 and 308: Molecular and biochemical basis of
- Page 309 and 310: Molecular and biochemical basis of
- Page 311 and 312: Molecular and biochemical basis of
- Page 313 and 314: Molecular and biochemical basis of
- Page 315 and 316: Molecular and biochemical basis of
- Page 317 and 318: Molecular and biochemical basis of
- Page 319 and 320: Molecular and biochemical basis of
- Page 321 and 322: Molecular and biochemical basis of
- Page 323 and 324: Molecular and biochemical basis of
- Page 325 and 326: Molecular and biochemical basis of
- Page 327 and 328: Molecular and biochemical basis of
- Page 329 and 330: Molecular and biochemical basis of
- Page 331: Molecular and biochemical basis of
- Page 335 and 336: Molecular and biochemical basis of
- Page 337 and 338: Molecular and biochemical basis of
- Page 339 and 340: Molecular and biochemical basis of
- Page 341 and 342: Molecular and biochemical basis of
- Page 343 and 344: Molecular and biochemical basis of
- Page 345 and 346: Molecular and biochemical basis of
- Page 347 and 348: Molecular and biochemical basis of
- Page 349 and 350: Molecular and biochemical basis of
- Page 351 and 352: Molecular and biochemical basis of
- Page 353 and 354: Molecular and biochemical basis of
- Page 355 and 356: Molecular and biochemical basis of
- Page 357 and 358: Molecular and biochemical basis of
- Page 359 and 360: Molecular and biochemical basis of
- Page 361 and 362: Molecular and biochemical basis of
- Page 363 and 364: Molecular and biochemical basis of
- Page 365 and 366: Molecular and biochemical basis of
- Page 367 and 368: Normal variation, population geneti
- Page 369 and 370: Normal variation, population geneti
- Page 371 and 372: Normal variation, population geneti
- Page 373 and 374: Normal variation, population geneti
- Page 375 and 376: Normal variation, population geneti
- Page 377 and 378: Normal variation, population geneti
- Page 379 and 380: Normal variation, population geneti
- Page 381 and 382: Normal variation, population geneti
Molecular and biochemical basis <strong>of</strong> disease<br />
P06.177<br />
sequence analysis <strong>of</strong> circadian clock modulators miR-132 and<br />
miR-219 and their targets RFX4 and PHLPP in mood Disorder<br />
Patients<br />
E. Saus 1 , V. Soria 2 , F. Vivarelli 1 , J. M. Crespo 2,3 , J. M. Menchón 2,3 , M. Urretavizcaya<br />
2,3 , X. Estivill 1,4 , M. Gratacòs 1 ;<br />
1 CIBERESP (CIBER en Epidemiología y Salud Pública), Genes and Disease<br />
Program and CeGen <strong>Barcelona</strong> Genotyping Node, Center for Genomic Regulation,<br />
<strong>Barcelona</strong>, Catalonia, Spain, 2 Mood Disorders Clinical and Research Unit,<br />
CIBER-SAM, Psychiatry Department, Bellvitge University Hospital, L’Hospitalet<br />
de Llobregat, <strong>Barcelona</strong>, Catalonia, Spain, 3 Department <strong>of</strong> Clinical Sciences,<br />
Bellvitge Campus, <strong>Barcelona</strong> University, <strong>Barcelona</strong>, Catalonia, Spain, 4 Experimental<br />
and Health Sciences Department, Pompeu Fabra University, <strong>Barcelona</strong>,<br />
Catalonia, Spain.<br />
It has been widely supported that circadian rhythms are involved in the<br />
pathophysiology <strong>of</strong> mood disorders (MD). Two brain-specific miRNAs<br />
(microRNAs) have been recently reported as modulators <strong>of</strong> endogenous<br />
circadian clock located in the suprachiasmatic nucleus in mice .<br />
The authors have functionally characterized miR-132 and miR-219<br />
within the context <strong>of</strong> circadian clock and gave experimental evidences<br />
<strong>of</strong> genes Rfx4 and Phlpp as respective targets. We first explored the<br />
conservation between species for both miRNAs and once the existence<br />
<strong>of</strong> hsa-miR-132 and hsa-miR-219 was corroborated in humans,<br />
we used different prediction programs to check the experimentally<br />
supported target sites RFX4 and PHLPP in humans. Specifically, mi-<br />
Randa predicted hsa-miR-132 to target RFX4 and TargetScan predicted<br />
PHLPP as a target site for hsa-miR-219, consistent with previous<br />
work in mice . Once both miRNAs with their respective target sites<br />
were confirmed in humans, we questioned whether these two miRNAs<br />
and their target genes RFX4 and PHLPP are altered in mood disorder<br />
patients . Thus, we re-sequenced both miRNAs and their respective<br />
target sites at RFX4 and PHLPP genes in a sample consisting <strong>of</strong> 365<br />
unrelated patients (218 Unipolar Major Depressive Disorder and 147<br />
Bipolar Disorder) diagnosed according to DSM-IV criteria . All patients<br />
completed the Spanish versions <strong>of</strong> the Seasonal Pattern Assessment<br />
Questionnaire and the Horne-Östberg Morningness-Eveningness<br />
Questionnaire. This is the first time that the circadian clock regulation<br />
by miRNAs is explored in mood disorder, representing a first step to<br />
elucidate the underlying mechanism <strong>of</strong> these proteins and the role <strong>of</strong><br />
these miRNAs in mood disorders .<br />
P06.178<br />
Allelic frequencies and heterozygosities <strong>of</strong> microsatellite<br />
markers covering the whole genome in the Korean<br />
J. Lee, M. Park, K. Kim, H. Lee, K. Kim, J. Jung, B. Oh, H. Kim;<br />
Center for Genome Science, National Institute <strong>of</strong> Health, Seoul, Republic <strong>of</strong><br />
Korea.<br />
Microsatellite markers are an essential tool for genetic linkage analysis<br />
because <strong>of</strong> their high polymorphism content . Four hundred commercially<br />
available markers covering the entire genome were genotyped<br />
from 578 sib individuals from 249 Korean families . Allelic frequencies<br />
and heterozygosities were determined for each marker loci and compared<br />
between Korean, Taiwanese, Japanese and Caucasian populations<br />
. In the three Asian populations, 10-13% <strong>of</strong> the markers had less<br />
than 0 .6 heterozygosity, whereas in the Caucasian population, only<br />
0 .5% <strong>of</strong> the markers had less than 0 .6 heterozygosity . Mean identical<br />
by descent (IBD) values were calculated for 578 sib individuals .Analysis<br />
<strong>of</strong> IBD values greater than 0 .5 suggested that markers with low<br />
heterozygosity can also provide positive linkages, at least for the IBD<br />
sharing method <strong>of</strong> model-free linkage analysis . The data presented in<br />
this study will be a useful reference for genome-wide screens <strong>of</strong> Koreans<br />
and comparative studies with other ethnic populations .<br />
P06.179<br />
Association study <strong>of</strong> migraine and 19 candidate genes involved<br />
in serotoninergic neurotransmission in a spanish population<br />
R. Corominas 1 , M. J. Sobrido 2,3 , E. Cuenca-León 1 , P. Blanco 4,3 , B. Narberhaus<br />
5 , M. Del Toro 1 , R. Leira 6 , J. López 6 , M. Ribasés 1 , A. Macaya 1 , B. Cormand<br />
7,3 ;<br />
1 Hospital Universitari Vall d’Hebron, <strong>Barcelona</strong>, Spain, 2 Fundación Pública<br />
Galera de Medicina Xenómica, Santiago de Compostela, Spain, 3 CIBER Enfermedades<br />
Raras, Instituto de Salud Carlos III, <strong>Barcelona</strong>, Spain, 4 Grupo de<br />
Medicina Xenómica, Universidad de Santiago de Compostela, Santiago de<br />
Compostela, Spain, 5Hospital General de Manresa, Manresa, Spain, 6Servicio de Neurología, Hospital Clínco de Santiago, Santiago de Compostela, Spain,<br />
7Departament de Genètica, Facultat de Biologia, Universitat de <strong>Barcelona</strong>,<br />
<strong>Barcelona</strong>, Spain.<br />
Migraine is a common neurological disorder with a complex inheritance<br />
pattern . Although the pathophysiology <strong>of</strong> the disease is not well<br />
understood, several studies suggest that serotonin-related genes may<br />
participate in its pathogenesis . The involvement <strong>of</strong> some <strong>of</strong> these<br />
genes has been studied in different migraine populations with conflicting<br />
results thus far .<br />
In the present study we aimed to evaluate the possible role <strong>of</strong> 19 genes<br />
involved in serotoninergic neurotransmission in the susceptibility to migraine<br />
in a Spanish population using a case-control approach based<br />
on SNPs . A total sample <strong>of</strong> 528 unrelated patients were recruited and<br />
diagnosed following the IInd International Criteria <strong>of</strong> Headache Disorders<br />
from the IHS (308 patients had migraine without aura and 220<br />
had migraine with aura) and compared to 528 sex-matched controls<br />
in which migraine was ruled out . All individuals were Spanish <strong>of</strong> Caucasoid<br />
origin from Catalonia and Galicia . SNP selection was based<br />
on genetic coverage parameters and genotyping was performed using<br />
SNPlex technology . Chi-square tests were used for the comparison<br />
<strong>of</strong> allele and genotype frequencies between the patient and control<br />
groups for each single SNP . Preliminary data <strong>of</strong> nominal associations<br />
suggest a contribution <strong>of</strong> HTR1E, HTR2B, HTR3B, MAOA and DDC in<br />
the genetic predisposition to migraine .<br />
P06.180<br />
Genetic diagnosis <strong>of</strong> Ataxia telangectasia and role <strong>of</strong><br />
mitochondria on it<br />
M. Houshmand;<br />
NIGEB, Tehran, Islamic Republic <strong>of</strong> Iran.<br />
Ataxia telangiectasia (AT) is an autosomal recessive disorder in<br />
1/40,000 to 1/100,000 in reported populations . There is a 25% possibility<br />
for having an affected child when parents are carrier for the<br />
ATM gene mutation . There is no cure available for this disease and<br />
prenatal testing is strongly recommended for prevention <strong>of</strong> this disease<br />
. Although the preferred method is the direct mutation analysis <strong>of</strong><br />
the ATM gene, the large size <strong>of</strong> the ATM gene with 63 exons and the<br />
large number <strong>of</strong> possible mutations in patients considerably limit efficiency<br />
<strong>of</strong> mutation analysis as a diagnostic choice. In this study, four<br />
molecular markers: D11S2179, D11S1787, D11S535, D11S1343 are<br />
genotyped in 19 unrelated families from different regions <strong>of</strong> Iran . All<br />
carriers and affected patients were diagnosed accurately . This method<br />
is effectively useful in prenatal diagnosis <strong>of</strong> AT .<br />
We also investigated mt-DNA deletions and haplogroups in AT patients .<br />
In this study, 24 Iranian patients suffering from AT and 100 normal<br />
controls were examined . mt-DNA was extracted from whole blood and<br />
examined by 6 primers for existence <strong>of</strong> mitochondrial deletions . We<br />
also amplified and sequenced the mtDNA HVS-I by standard sequencing<br />
techniques . mtDNA deletions were observed in 54 .1% (13/24) <strong>of</strong><br />
patients (8 .9 kb deletion in all samples, 5 .0 kb in one and 7 .5 kb in two<br />
patients), representing mtDNA damage which may be due to oxidative<br />
stress in mitochondria . Our results showed that there is no association<br />
between mtDNA haplogroups and AT . This data may indicate involvement<br />
<strong>of</strong> mitochondrial damage in the pathogenesis <strong>of</strong> AT .<br />
P06.181<br />
Role <strong>of</strong> mitochondria in Friedreich Ataxia<br />
M. Houshmand;<br />
NiGEB, Tehran, Islamic Republic <strong>of</strong> Iran.<br />
Friedreich’s Ataxia (FA) is the commonest genetic cause <strong>of</strong> ataxia<br />
and is associated with the expansion <strong>of</strong> a GAA repeat in intron 1 <strong>of</strong><br />
the frataxin gene . Mitochondrial DNA (mtDNA) could be considered a<br />
candidate modifier factor for FA disease, since mitochondrial oxidative<br />
stress is thought to be involved in the pathogenesis <strong>of</strong> this disease . The<br />
expansion (GAA) repeat in the first intron causes decreased frataxin<br />
expression by interfering with transcription .: Activity <strong>of</strong> mitochondrial<br />
respiratory chain complex I (measured as NADH ferricyanide reductase)<br />
and intracellular ATP measurement was performed on lymphocyte<br />
<strong>of</strong> FA patients (n =12) and control subjects (n =25) . Common deletion<br />
were identified and confirmed by southern blotting in FA patients.<br />
Homozygous GAA expansion was found in 21 (84%) <strong>of</strong> all cases . In<br />
four cases (16%), no expansion was observed, ruling out the diagnosis